These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1948085)

  • 1. Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primates.
    Fareed J; Coker S; Iqbal O; Hoppensteadt D; Walenga JM
    Semin Thromb Hemost; 1991; 17 Suppl 2():147-52. PubMed ID: 1948085
    [No Abstract]   [Full Text] [Related]  

  • 2. Protamine sulfate neutralization of lactobionic acid amides.
    Hoppensteadt D; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 2():153-7. PubMed ID: 1948086
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of subcutaneous administration of lactobionic acid on coagulation and platelet function].
    Kirchmaier CM; Lindhoff E; Basic-Micic M; Breddin HK
    Vasa Suppl; 1991; 33():168. PubMed ID: 1788660
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical studies on sulfated lactobionic acid amides.
    Klauser RJ; Meinetsberger E; Raake W
    Semin Thromb Hemost; 1991; 17 Suppl 1():118-25. PubMed ID: 1648790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic and anticoagulant properties of synthetic polyanions: sulfated bis-aldonic acid amides.
    Klauser RJ; Raake W; Meinetsberger E; Zeiller P
    J Pharmacol Exp Ther; 1991 Oct; 259(1):8-14. PubMed ID: 1656031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant and antithrombotic activity of maltodapoh, a novel sulfated tetrasaccharide.
    Martin DJ; Toce JA; Anevski PJ; Tollefsen DM; Abendschein DR
    J Pharmacol Exp Ther; 1999 Feb; 288(2):516-21. PubMed ID: 9918553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic profile of the antithrombotic and bleeding actions of sulfated lactobionic acid amides.
    Raake W; Klauser RJ; Meinetsberger E; Zeller P; Elling H
    Semin Thromb Hemost; 1991; 17 Suppl 1():129-35. PubMed ID: 2068566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity.
    Sugidachi A; Asai F; Koike H
    Thromb Res; 1993 Jan; 69(1):71-80. PubMed ID: 8465276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hypersulfated lactobionic acid amides on tissue plasminogen activator release.
    Klöcking HP; Hoffmann A; Fareed J
    Semin Thromb Hemost; 1991 Oct; 17(4):379-84. PubMed ID: 1803506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide.
    Callas DD; Hoppensteadt DA; Jeske W; Iqbal O; Bacher P; Ahsan A; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():49-57. PubMed ID: 8362269
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of lactobionic acid on the kinetics of thrombin in human plasma.
    Béguin SS; Dol F; Hemker HC
    Semin Thromb Hemost; 1991; 17 Suppl 1():126-8. PubMed ID: 2068565
    [No Abstract]   [Full Text] [Related]  

  • 12. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.
    Cipriani TR; Gracher AH; de Souza LM; Fonseca RJ; Belmiro CL; Gorin PA; Sassaki GL; Iacomini M
    Thromb Haemost; 2009 May; 101(5):860-6. PubMed ID: 19404539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protamine sulfate neutralization of the anticoagulant activity of Aprosulate, a synthetic sulfated lactobionic acid amide.
    Kijowski R; Hoppensteadt D; Jeske W; Fareed J
    Thromb Res; 1994 Mar; 73(5):349-59. PubMed ID: 8016819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current pharmacological aspects of antithrombotic drugs].
    Stroescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):325-7. PubMed ID: 14367
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic activities of aprosulate sodium (LW 10082) and its neutralization by protamine.
    Raake W; Klauser RJ; Meinetsberger E
    Semin Thromb Hemost; 1993; 19 Suppl 1():183-5. PubMed ID: 8362265
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae.
    Martinichen-Herrero JC; Carbonero ER; Sassaki GL; Gorin PA; Iacomini M
    Int J Biol Macromol; 2005 Mar; 35(1-2):97-102. PubMed ID: 15769521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 20. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.